NIMBLE-CRC: NeoImmunoModulation Before Leveraging Excision in Colorectal Rectal Cancer

NCT07677579 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Metastatic

Interventions

DRUG: Retifanlimab
DRUG: Zanzalintinib

Sponsor

Northwell Health